These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26313502)

  • 41. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contemporary management of regional nodes in penile cancer-improvement of survival?
    Djajadiningrat RS; Graafland NM; van Werkhoven E; Meinhardt W; Bex A; van der Poel HG; van Boven HH; Valdés Olmos RA; Horenblas S
    J Urol; 2014 Jan; 191(1):68-73. PubMed ID: 23917166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delays in the diagnosis and initial treatment of bladder cancer in Western Australia.
    McCombie SP; Bangash HK; Kuan M; Thyer I; Lee F; Hayne D
    BJU Int; 2017 Nov; 120 Suppl 3():28-34. PubMed ID: 28661572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial symptoms and delay in patients with penile carcinoma.
    Skeppner E; Andersson SO; Johansson JE; Windahl T
    Scand J Urol Nephrol; 2012 Oct; 46(5):319-25. PubMed ID: 22989150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organ-preserving surgery for penile cancer: description of techniques and surgical outcomes.
    Veeratterapillay R; Sahadevan K; Aluru P; Asterling S; Rao GS; Greene D
    BJU Int; 2012 Dec; 110(11):1792-5. PubMed ID: 22551234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective analysis on timeframes of referral, diagnosis and treatment of patients with endometrial carcinomas in Dunedin Hospital, 2008-2011.
    Kang MY; Sykes P; Herbison PY; Petrich S
    N Z Med J; 2013 Oct; 126(1384):84-95. PubMed ID: 24162633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Squamous cell carcinoma of the penis: a retrospective review of forty-five patients in northwest Louisiana.
    Carver BS; Mata JA; Venable DD; Eastham JA
    South Med J; 2002 Aug; 95(8):822-5. PubMed ID: 12190215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic flow for all patients referred with non-specific symptoms of cancer to a diagnostic centre in Denmark: A descriptive study.
    Damhus CS; Brodersen JB; Nielsen GL
    Eur J Gen Pract; 2024 Dec; 30(1):2296108. PubMed ID: 38179994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability.
    Ingeman ML; Christensen MB; Bro F; Knudsen ST; Vedsted P
    BMC Cancer; 2015 May; 15():421. PubMed ID: 25990247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma.
    Hadway P; Smith Y; Corbishley C; Heenan S; Watkin NA
    BJU Int; 2007 Sep; 100(3):561-5. PubMed ID: 17578518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time to diagnosis and treatment for cancer patients in the Netherlands: Room for improvement?
    Helsper CCW; van Erp NNF; Peeters PPHM; de Wit NNJ
    Eur J Cancer; 2017 Dec; 87():113-121. PubMed ID: 29145037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploration of the possible effect on survival of lead-time associated with implementation of cancer patient pathways among symptomatic first-time cancer patients in Denmark.
    Jensen H; Vedsted P
    Cancer Epidemiol; 2017 Aug; 49():195-201. PubMed ID: 28711854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer patients' experiences with urgent referrals to cancer patient pathways.
    Sandager M; Jensen H; Lipczak H; Sperling CD; Vedsted P
    Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12927. PubMed ID: 30303244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidisciplinary first-day consultation accelerates diagnostic procedures and throughput times of patients in a head-and-neck cancer care pathway, a mixed method study.
    van Huizen LS; Dijkstra PU; van der Laan BFAM; Reintsema H; Ahaus KTB; Bijl HP; Roodenburg JLN
    BMC Health Serv Res; 2018 Oct; 18(1):820. PubMed ID: 30373578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients.
    Leijte JA; Kirrander P; Antonini N; Windahl T; Horenblas S
    Eur Urol; 2008 Jul; 54(1):161-8. PubMed ID: 18440124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Malignant and premalignant lesions of the penis.
    Arya M; Kalsi J; Kelly J; Muneer A
    BMJ; 2013 Mar; 346():f1149. PubMed ID: 23468288
    [No Abstract]   [Full Text] [Related]  

  • 57. Emerging Systemic Therapies for the Management of Penile Cancer.
    Gupta S; Sonpavde G
    Urol Clin North Am; 2016 Nov; 43(4):481-491. PubMed ID: 27717434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in waiting time for diagnosis and treatment of head and neck cancer - a fast track study.
    Toustrup K; Lambertsen K; Birke-Sørensen H; Ulhøi B; Sørensen L; Grau C
    Acta Oncol; 2011 Jun; 50(5):636-41. PubMed ID: 21261506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of penile cancer].
    Nechiporenko AZ; Nechiporenko NA; Savkova NV
    Urol Nefrol (Mosk); 1981; (2):39-42. PubMed ID: 7222311
    [No Abstract]   [Full Text] [Related]  

  • 60. Work-up times in an integrated brain cancer pathway.
    Laursen EL; Rasmussen BK
    Dan Med J; 2012 May; 59(5):A4438. PubMed ID: 22549491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.